Medicare Enrolled
Dr. Gautam Moorjani, MD
Hospitalist Physician · San Antonio, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Moorjani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Moorjani?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Moorjani
Dr. Gautam Moorjani is a hospitalist physician in San Antonio, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Moorjani performed 168,893 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Moorjani received a total of $19,222 from 53 pharmaceutical and/or device companies across 915 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Moorjani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 0% volume in TX
$19,222 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗168,893
Medicare services
Top 0% in TX for hospitalist physician
Not available
Unique patients (not deduplicated)
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
39,406 | $10 | $48 |
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
38,800 | $4 | $19 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
30,300 | $33 | $134 |
| Tocilizumab injection (Actemra) | 27,521 | $4 | $17 |
| Romosozumab injection (Evenity) for osteoporosis | 10,290 | $8 | $28 |
| Denosumab injection (Prolia/Xgeva) | 8,460 | $18 | $42 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
3,781 | $22 | $114 |
| Infliximab-abda biosimilar injection, 10 mg This code represents the administration of a 10 mg dose of infliximab-abda, a biosimilar medication. It covers the injection of this specific pharmaceutical product. |
1,570 | $29 | $119 |
| Extended-release steroid injection (Zilretta) An injection of triamcinolone acetonide using a preservative-free, extended-release microsphere formulation. The dosage is measured in milligrams. |
1,184 | $13 | $42 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
965 | $88 | $253 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
923 | $10 | $26 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
855 | $5 | $14 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
833 | $8 | $20 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
815 | $3 | $6 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
798 | $97 | $399 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
436 | $17 | $44 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
419 | $56 | $222 |
| Complement and antigen measurement A laboratory test to measure levels of complement proteins and antigens in the blood. |
164 | $11 | $29 |
| Immunoassay substance analysis, multiple step method A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material. |
138 | $11 | $28 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
123 | $21 | $85 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
100 | $124 | $497 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
90 | $87 | $258 |
| DNA antibody test (native or double-stranded) A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body. |
85 | $13 | $35 |
| Measurement of dna antibody, single stranded | 85 | $12 | $29 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
79 | $29 | $72 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
73 | $4 | $12 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
72 | $12 | $32 |
| Rheumatoid factor level | 69 | $5 | $15 |
| Injection, methylprednisolone acetate, 40 mg | 54 | $6 | $15 |
| Hyaluronan injection (Euflexxa) for joint An injection of hyaluronan or its derivative, specifically Euflexxa, administered directly into a joint space. |
48 | $101 | $311 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
47 | $6 | $17 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
40 | $47 | $166 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
39 | $3 | $13 |
| Autoimmune disorder screening test A laboratory test used to screen for the presence of autoimmune disorders. |
35 | $11 | $29 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
35 | $12 | $47 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
30 | $71 | $75 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
29 | $30 | $61 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
22 | $11 | $42 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
20 | $8 | $28 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
18 | $3 | $4 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
16 | $59 | $170 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
13 | $15 | $38 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $115 | $331 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
44.0% high complexity
52.5% medium
3.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$19,222
Total received (2018-2024)
Avg $2,746/year across 7 years
Top 1% in TX for hospitalist physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
915
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,550
2023
$2,353
2022
$2,663
2021
$2,052
2020
$1,741
2019
$5,336
2018
$2,528
Payments by company (2024)
Janssen Biotech, Inc.
$441
Amgen Inc.
$437
Novartis Pharmaceuticals Corporation
$369
UCB, Inc.
$218
ABBVIE INC.
$213
Johnson & Johnson Health Care Systems Inc.
$150
Lilly USA, LLC
$143
Mallinckrodt Hospital Products Inc.
$117
Radius Health, Inc.
$100
GlaxoSmithKline, LLC.
$77
PFIZER INC.
$75
Fresenius Kabi USA, LLC
$49
E.R. Squibb & Sons, L.L.C.
$41
Teva Pharmaceuticals USA, Inc.
$31
Aurinia Pharma U.S., Inc.
$24
Ultragenyx Pharmaceutical Inc.
$22
ANI Pharmaceuticals, Inc.
$17
SCILEX PHARMACEUTICALS INC.
$14
SHIELD THERAPEUTICS INC
$13
Top 3 companies account for 48.9% of 2024 payments
All-time payments by company (2018-2024) ›
Horizon Therapeutics plc
$3,173
Amgen Inc.
$2,384
Novartis Pharmaceuticals Corporation
$1,790
Janssen Biotech, Inc.
$1,398
UCB, Inc.
$1,334
E.R. Squibb & Sons, L.L.C.
$1,035
Lilly USA, LLC
$1,013
Mallinckrodt Hospital Products Inc.
$926
PFIZER INC.
$785
GlaxoSmithKline, LLC.
$525
Genentech USA, Inc.
$513
AbbVie, Inc.
$434
GENZYME CORPORATION
$409
Flexion Therapeutics, Inc.
$354
Horizon Pharma plc
$306
Radius Health, Inc.
$271
ABBVIE INC.
$258
SANOFI-AVENTIS U.S. LLC
$258
Actelion Pharmaceuticals US, Inc.
$184
Ferring Pharmaceuticals Inc.
$173
Aurinia Pharma U.S., Inc.
$156
Johnson & Johnson Health Care Systems Inc.
$150
Celgene Corporation
$130
AbbVie Inc.
$118
Pacira Therapeutics, Inc.
$107
AstraZeneca Pharmaceuticals LP
$105
Janssen Scientific Affairs, LLC
$91
Fresenius Kabi USA, LLC
$77
Antares Pharma, Inc.
$75
Organon LLC
$69
ANI Pharmaceuticals, Inc.
$67
Merck Sharp & Dohme Corporation
$67
Mallinckrodt Enterprises LLC
$64
Exeltis, USA Inc.
$37
Hikma Pharmaceuticals USA
$35
Takeda Pharmaceuticals U.S.A., Inc.
$35
Mallinckrodt LLC
$31
Teva Pharmaceuticals USA, Inc.
$31
Bioventus LLC
$29
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
Ultragenyx Pharmaceutical Inc.
$22
Octapharma USA, Inc.
$20
FIDIA PHARMA USA INC.
$17
Sandoz Inc.
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
West-Ward Pharmaceuticals
$15
SCILEX PHARMACEUTICALS INC.
$14
Merck Sharp & Dohme LLC
$14
Ironwood Pharmaceuticals, Inc
$14
Endo Pharmaceuticals Inc.
$13
Kiniksa Pharmaceuticals, Ltd.
$13
SHIELD THERAPEUTICS INC
$13
MEDEXUS PHARMA, INC.
$12
Top 3 companies account for 38.2% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ACTHAR · AMJEVITA · AREXVY · AVSOLA · Actemra · Adempas · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CUVITRU · Cimzia · Crysvita · DUZALLO · Durolane · EMBEDA · EUFLEXXA · EVENITY · Enbrel · FORTEO · HADLIMA · HYRIMOZ · Humira · Hymovis · IDACIO · INFLECTRA · KEVZARA · KRYSTEXXA · LUPKYNIS · LYRICA · Mitigare · NASCOBAL · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONTRUZANT · OPSUMIT · ORENCIA · OTREXUP · Otezla · Otrexup · PENNSAID · PNEUMOVAX 23 · PREVNAR 13 · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMLANDI · SIMPONI · SIMPONI ARIA · SKYRIZI · SYNVISC-ONE · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · UPTRAVI · Uloric · XELJANZ · ZTLido · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hospitalist physicians in nearby ZIP areas
144
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
SOUTH TEXAS SPINE AND SURGICAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Moorjani is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Moorjani experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Moorjani performed 39,406 golimumab infusion (simponi aria) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Moorjani receive payments from pharmaceutical companies?
Yes. Dr. Moorjani received a total of $19,222 from 53 companies across 915 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Moorjani's costs compare to other hospitalist physicians in San Antonio?
Dr. Moorjani's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Moorjani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hospitalist Physicians in San Antonio
Browse hospitalist physicians in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Hospitalist Physicians in TX
Hospitalist physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hospitalist Physicians in TX
Which TX hospitalist physicians receive the most from drug and device companies.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology